DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsAllison R. Hanaford, Eric H. Raabe, Alykhan F. Shamji et al.|Clinical Cancer Research|2016Cited by 68
DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic TargetsAllison R. Hanaford, Pablo Tamayo, Antoinette Price et al.|Unknown|2016Cited by 8
Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12CMatthew L. Condakes, Michelle L. Stewart|Nature Communications|2026Cited by 3
Supplementary Figure 3 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsAllison R. Hanaford, Eric H. Raabe, Tenley C. Archer et al.|Unknown|2023Cited by 0
Supplementary Figure 2 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsAllison R. Hanaford, Eric H. Raabe, Tenley C. Archer et al.|Unknown|2023Cited by 0